Skip to content
Home/Companies/Biotech/Pharmeste

Pharmeste

Biotech·Italy·Active·19yr hold
Entry
2007
Hold
19yr
Status
Active

Who owns Pharmeste?

Pharmeste is currently owned by Principia SGR through Principia Fund (2007 vintage), since 2007.

Hand-verified · updated 2026-07-23

Principia SGR
Investor
Principia SGR
Principia Fund · 2007 · VC

Key facts

HQItaly
SectorBiotech
StatusActive

More from Principia Fund

Other portfolio companies in the same fund.

Banzai
Exited 2015
E-commerceItaly· 2010
EOS (Ethical Oncology Science)
Exited 2013
BiotechItaly· 2009
to

More Principia SGR portfolio companies

From the same investor, across funds.

Comftech
Active
MedTechItaly· 2018
Compass Pathways
Compass Pathways
Exited 2020
BiotechUK· 2018
CrestOptics
CrestOptics
Active
MedTechItaly· 2018
Enterome
Enterome
Active
BiotechFrance· 2018
Gada
Gada
Active
MedTechItaly· 2018
Trifarma
Trifarma
Active
PharmaItaly· 2017

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track PharmEste

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy PharmEste?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on PharmEste.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue